F Dx Advisors, Inc. Guardant Health, Inc. Transaction History

F Dx Advisors, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$43.66 - $61.0 $45,624 - $63,745	-1,045 Reduced 19.44%	4,331 $233,000
Q2 2022 Aug 03, 2022	BUY	$28.82 - $77.35 $23,661 - $63,504	821 Added 18.02%	5,376 $217,000
Q1 2022 May 03, 2022	SELL	$48.25 - $100.49 $34,547 - $71,950	-716 Reduced 13.58%	4,555 $302,000
Q4 2021 Feb 01, 2022	SELL	$88.71 - $120.43 $23,951 - $32,516	-270 Reduced 4.87%	5,271 $527,000
Q3 2021 Oct 08, 2021	BUY	$98.77 - $132.17 $34,964 - $46,788	354 Added 6.82%	5,541 $693,000
Q2 2021 Aug 05, 2021	BUY	$109.77 - $165.68 $130,845 - $197,490	1,192 Added 29.84%	5,187 $644,000
Q1 2021 Apr 14, 2021	BUY	$127.04 - $179.1 $430,030 - $606,253	3,385 Added 554.92%	3,995 $610,000
Q1 2021 Apr 13, 2021	SELL	$127.04 - $179.1 $458,995 - $647,088	-3,613 Reduced 85.56%	610 $93,000
Q4 2020 Feb 08, 2021	SELL	$99.96 - $135.93 $24,190 - $32,895	-242 Reduced 5.42%	4,223 $544,000
Q3 2020 Nov 12, 2020	BUY	$80.32 - $111.8 $77,107 - $107,328	960 Added 27.39%	4,465 $499,000
Q2 2020 Jul 22, 2020	BUY	$60.49 - $97.5 $212,017 - $341,737	3,505 New	3,505 $284,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.59B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on F Dx Advisors, Inc. with notifications on news.